Imaging AI Moves From Detection to Capacity Control – May 22, 2026
A light approval week revealed a sharper market signal: imaging AI is being judged by its ability to protect constrained clinical pathways. 🎧 Listen to this week’s Marketstrat Pulse Insight: A narrow approval week with a broad operating signal The week ending May 22, 2026, did not produce a flood of new imaging AI approvals. […]
Imaging AI’s Operating Stack Moves From Model Proof to Capacity Control – May 15, 2026
GE, Siemens, RadNet, Fujifilm, AGFA, Viz.ai, Lumexa, and CMS show how imaging value is moving into uptime, workflow, authorization, and utilization economics. The most important imaging AI signals this week were not isolated algorithms. They were operating-stack signals. MRI uptime, interventional acquisition, outpatient slot capacity, enterprise imaging, prior authorization, and procedure workflow all moved into […]
Imaging AI Enters Its Operating Era – May 8, 2026
Roche/PathAI, ACR/SIIM governance, Siemens and Philips earnings, CMS prior-auth digitization, and new workflow clearances show imaging value moving beyond model performance. Imaging AI’s next phase is less about proving algorithms and more about governing, monitoring, integrating, and monetizing them inside clinical workflow. This week’s Marketstrat Pulse highlights five signals: Roche’s PathAI acquisition, the ACR/SIIM AI […]
Imaging AI’s New Moat Is Workflow Control – May 1, 2026
Capital, OEM strategy, provider consolidation, and procedural imaging are shifting the market from point algorithms to operating platforms. 🎧 Listen to this week’s Marketstrat Pulse Insight: This week’s Marketstrat | Pulse Insights points to a sharper imaging AI market. Aidoc’s $150 million financing, GE HealthCare’s Advanced Imaging Solutions reorganization, RadNet’s Idaho imaging joint venture, Abbott’s […]
Imaging AI’s New Moat: Coverage Speed, Workflow Control, and Evidence That Actually Moves Operations – April 24, 2026
This week’s medical imaging AI signal was not another model launch. It was the market moving toward reimbursable, governed, and routed workflow infrastructure. 🎧 Listen to this week’s Marketstrat Pulse Insight: The medical imaging AI market is entering a more disciplined phase. For the past several years, the category has been defined by algorithm count, […]
Owned Workflow Gets Paid: Imaging AI Reimbursement, Spectral CT, PACS-AI Consolidation, and Image-Guided MIS
Reimbursable chest-CT AI, modality-native software, and platform ownership shift value from model novelty to monetized workflow control. Marketstrat® Pulse Insights | Week ending April 17, 2026Coverage: Medical Imaging AI | Enterprise Imaging IT | Imaging Reimbursement | AI-Enabled MedTech | Image-Guided MIS 🎧 Listen to this week’s Marketstrat Pulse Insight: If the April 10 week […]
Routability Becomes the Moat – April 10, 2026
Prior authorization reform, workflow control, and provider-scale validation re-rank imaging AI KEY TAKEAWAYS COMMERCIALIZATION SURFACE MAP The Commercialization Surface Map explains where this week’s value sat. It plots the major signals by deployment-surface control and clinical or regulatory novelty, with bubble size reflecting strategic impact. The pattern is the story: the strongest signals clustered where […]
Validated Workflow Starts to Beat the Algorithm Pitch – April 3, 2026
Dual ACC physiology trials, lower-operator maternal ultrasound, and distribution-rail concentration push imaging software closer to budgetable infrastructure ONE BIG THING The most important shift this week was not another point-model launch. It was convergence: two large, randomized ACC readouts materially de-risked software-first coronary physiology, Butterfly cleared a lower-skill obstetric ultrasound workflow at the point of […]
Commercialization Plumbing Beats Novelty – March 27, 2026
CMS coding, provider-IT rails, and MRI resilience reset the imaging AI stack ONE BIG THING This week’s most important shift was that imaging AI moved another step away from “interesting software” and toward operational infrastructure. CMS published HCPCS G0680 (effective April 1) for software analysis of coronary artery calcium and aortic valve calcification from chest […]
Platform Control Becomes Owned Infrastructure; Screening AI Shows Real Labor Proof – March 20, 2026
GE’s Intelerad close turns enterprise imaging strategy into balance-sheet reality, while new screening evidence and cyber/helium disruptions sharpen what buyers will actually fund ONE BIG THING Enterprise imaging crossed from conference narrative into owned infrastructure this week: GE’s Intelerad close made platform control tangible, new breast-screening AI data made labor relief more credible, and cyber/helium […]
